Antibiotic therapy of mild community-acquired pneumonia in inpatients
Molchanova, O.V.; Suleĭmanov, S.S.; Ostrovskiĭ, A.B.
Antibiotiki i Khimioterapiia 54(5-6): 65-68
2009
ISSN/ISBN: 0235-2990 PMID: 20052921 Document Number: 632207
From the clinicoeconomic viewpoints the treatment of community-acquired pneumonia in patients without risk factors under hospital conditions with aminopenicillins was more appropriate, whereas for the treatment of patients with risk factors the following scheme of antibiotic therapy was advantageous: a beta-lactam (cefotaxime/ceftriaxone) in combination with a macrolide (azithromycin). The recommended therapy provided statistically lower percentage of negative pneumonia processes and decreased the treatment expenditures.